We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ELISA:OMXHEXElisa Oyj Class A Analysis

Data as of 2026-06-19 - not real-time

€38.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Elisa Oyj trades around €38, just above the identified support level of €37.78 and well below its 20‑day, 50‑day and 200‑day moving averages (≈€40.15, €40.79 and €41.01), signaling a clear bearish trend. Technical gauges reinforce this view: the MACD is in a bearish configuration, the RSI sits at a low 28 pointing to oversold conditions, and 30‑day volatility is moderate at 15.2%. The stock’s beta is near zero, indicating minimal sensitivity to broader market moves, while the Fear & Greed Index reads “Extreme Greed,” suggesting market optimism may be overstated. Valuation metrics further highlight concerns – the DCF‑derived fair value is roughly €20, less than half the current price, and both the P/E (17.8) and P/B (4.5) exceed industry averages. Despite an attractive dividend yield of 6.18%, the payout ratio is high at 82.7% and the balance sheet is levered (Debt/Equity ≈ 115%), raising questions about dividend sustainability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price hovering just above technical support at €37.78
  • RSI at 28 indicating oversold conditions
  • bearish MACD histogram and SMA alignment reinforcing downward bias

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • valuation gap versus DCF fair value (~€20) suggests limited upside
  • high dividend yield but payout ratio near 83% may strain cash flow
  • stable operating cash flow provides some cushion despite leverage

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • significant leverage (Debt/Equity >115%) increases financial risk
  • modest revenue contraction (-1.3%) limits growth prospects
  • current multiples are above peers, indicating overvaluation

Key Metrics & Analysis

Financial Health

Revenue Growth-1.30%
Profit Margin15.26%
P/E Ratio17.8
ROE25.17%
ROA8.59%
Debt/Equity115.75
P/B Ratio4.5
Op. Cash Flow€698.5M
Free Cash Flow€352.3M
Industry P/E16.7

Technical Analysis

TrendBearish
RSI28.1
Support€37.78
Resistance€41.90
MA 20€40.15
MA 50€40.79
MA 200€41.01
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair Value€19.98
Target Price€42.27
Upside/Downside11.24%
GradeOvervalued
TypeValue
Dividend Yield6.18%

Risk Assessment

Beta0.00
Volatility15.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.